Burns LJ - Search Results

1

Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.

Bachanova V, Burns LJ, Ahn KW, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM, Cairo MS, Cashen AF, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Ghosh N, Holmberg LA, Inwards DJ, Kanate AS, Lazarus HM, Malone AK, Munker R, Mussetti A, Norkin M, Prestidge TD, Rowe JM, Satwani P, Siddiqi T, Stiff PJ, William BM, Wirk B, Maloney DG, Smith SM, Sureda AM, Carreras J, Hamadani M; Center for International Blood and Marrow Transplant Research Lymphoma Working Committee. Bachanova V, et al. Among authors: burns lj. Biol Blood Marrow Transplant. 2015 Sep;21(9):1605-11. doi: 10.1016/j.bbmt.2015.05.007. Epub 2015 May 14. Biol Blood Marrow Transplant. 2015. PMID: 25983043 Free PMC article. Clinical Trial.

2

BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.

Gingrich RD, Ginder GD, Burns LJ, Wen BC, Fyfe MA. Gingrich RD, et al. Among authors: burns lj. Blood. 1990 Jun 15;75(12):2276-81. Blood. 1990. PMID: 2350574 Free article.

3

Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival.

Burns LJ, Daniels KA, McGlave PB, Miller WJ, Ramsay NK, Kersey JH, Weisdorf DJ. Burns LJ, et al. Bone Marrow Transplant. 1995 Jul;16(1):13-8. Bone Marrow Transplant. 1995. PMID: 7581112

4

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ. Miller JS, et al. Among authors: burns lj. Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44. Biol Blood Marrow Transplant. 1997. PMID: 9209739 Clinical Trial.

5

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.

Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P. Weisdorf D, et al. Biol Blood Marrow Transplant. 1997 Oct;3(4):217-23. Biol Blood Marrow Transplant. 1997. PMID: 9360784 Clinical Trial.

6

A novel four-drug ablative regimen with hemopoietic stem cell rescue for patients with breast cancer: a phase II study.

Gingrich RD, Lee CK, Hohl R, Joyce J, Burns LJ, Tamaki K, Wen BC, Scott S. Gingrich RD, et al. Among authors: burns lj. Biol Blood Marrow Transplant. 1999;5(2):86-93. doi: 10.1053/bbmt.1999.v5.pm10371360. Biol Blood Marrow Transplant. 1999. PMID: 10371360 Free article. Clinical Trial.

7

A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.

Orchard PJ, Rogosheske J, Burns L, Rydholm N, Larson H, DeFor TE, Ramsay NK, Weisdorf D. Orchard PJ, et al. Biol Blood Marrow Transplant. 1999;5(6):386-93. doi: 10.1016/s1083-8791(99)70015-7. Biol Blood Marrow Transplant. 1999. PMID: 10595816 Free article. Clinical Trial.

8

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.

Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ. Lickliter JD, et al. Among authors: burns lj. Bone Marrow Transplant. 2000 Oct;26(7):723-8. doi: 10.1038/sj.bmt.1702606. Bone Marrow Transplant. 2000. PMID: 11042652 Free article.

9

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM. Lazarus HM, et al. Among authors: burns lj. Bone Marrow Transplant. 2001 Feb;27(4):387-96. doi: 10.1038/sj.bmt.1702796. Bone Marrow Transplant. 2001. PMID: 11313668

10

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.

MacMillan ML, Weisdorf DJ, Davies SM, DeFor TE, Burns LJ, Ramsay NK, Wagner JE, Blazar BR. MacMillan ML, et al. Among authors: burns lj. Biol Blood Marrow Transplant. 2002;8(1):40-6. doi: 10.1053/bbmt.2002.v8.pm11858189. Biol Blood Marrow Transplant. 2002. PMID: 11858189 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page